Olmesact Tablet 20mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Korea Daiichi Sankyo Co., Ltd.
MFDS item code 201305058 · Approved 2013.02.15 · Insurance code 680900170
This product's status changed to Approval withdrawn on 2025.12.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is persistently high without a specific cause. This medication effectively lowers blood pressure, reducing the burden on the heart and blood vessels. It also helps prevent complications, thereby decreasing the risk of stroke and heart disease. Continuous treatment aids in the stable management of blood pressure. It is essential to use this medication according to the dosage prescribed by a physician based on the patient's health condition. This medication is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, administered regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time every day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while carefully monitoring their condition. <Elderly> No dose adjustment is required when administering this drug to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased to a maximum of 20mg once daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
Safety and efficacy for pediatric patients have not been established, so no dosage instructions are provided.
This medication can cause serious harm to the fetus and newborn if administered to women in their second and third trimesters of pregnancy, so if pregnancy is confirmed, discontinue use immediately. Patients with allergies to any ingredient in this medication, patients undergoing kidney dialysis, patients with severe liver disease, or patients with bile duct obstruction should not take this medication. Additionally, patients with hereditary lactose intolerance should avoid taking this medication. Patients with reduced blood volume or salt may experience hypotension, so it is crucial to confirm their condition thoroughly before starting treatment and to monitor closely as needed. This medication can affect kidney function, so patients with kidney disease or those who have undergone kidney transplants should have their kidney function regularly checked through blood tests. There is a risk of hyperkalemia, so especially patients with heart failure or compromised kidney function should have their potassium levels monitored regularly. Patients with aortic or mitral valve stenosis, obstruction, and hypertrophic heart disease need to take special care when taking this medication. Dizziness may occur during treatment, so it is advisable to avoid dangerous activities such as working at heights or driving. Possible side effects during treatment may include dizziness, headache, back pain, indigestion, chest pain, rashes, which are mostly mild and temporary. If severe side effects or allergic reactions are suspected, immediately consult healthcare professionals. When taken with other antihypertensive medications or potassium-sparing diuretics, this medication may increase serum potassium levels, so careful monitoring is required under the guidance of a physician. It is safer for pregnant or breastfeeding women to avoid taking this medication, and breastfeeding women should carefully consider whether to take this medication. Safety for children has not been established, so it should not be administered to children. Elderly patients may have increased drug concentration in the body, necessitating dosage adjustment and caution. In case of overdose, symptoms such as hypotension or palpitations may occur, and if such symptoms arise, notify healthcare professionals immediately. Long-term use of this medication has not been reported to present a carcinogenic risk; however, it is crucial to consistently monitor health status during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 degree and 25 degrees Celsius. This ensures the effectiveness and safety of the medication.
White round film-coated tablets
28 tablets (14 tablets/PTP X 2)/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Korea Daiichi Sankyo Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.